UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by Ables Iannone Moore & Associates Inc.

Ables Iannone Moore & Associates Inc. grew its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 1.0% during the fourth quarter, HoldingsChannel.com reports. The firm owned 3,848 shares of the healthcare conglomerate’s stock after purchasing an additional 37 shares during the period. UnitedHealth Group makes up approximately 1.2% of Ables Iannone Moore & Associates Inc.’s holdings, making the stock its 17th biggest holding. Ables Iannone Moore & Associates Inc.’s holdings in UnitedHealth Group were worth $1,947,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. International Assets Investment Management LLC raised its position in shares of UnitedHealth Group by 78,814.4% during the 3rd quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock valued at $3,096,896,000 after acquiring an additional 5,290,025 shares in the last quarter. Lone Pine Capital LLC bought a new stake in shares of UnitedHealth Group during the 2nd quarter valued at about $480,903,000. Dimensional Fund Advisors LP lifted its holdings in UnitedHealth Group by 30.0% in the second quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock worth $1,942,956,000 after acquiring an additional 880,183 shares during the last quarter. Accredited Investors Inc. raised its position in shares of UnitedHealth Group by 9,235.4% during the 3rd quarter. Accredited Investors Inc. now owns 784,924 shares of the healthcare conglomerate’s stock worth $458,929,000 after purchasing an additional 776,516 shares during the period. Finally, Raymond James & Associates grew its stake in UnitedHealth Group by 33.1% during the 3rd quarter. Raymond James & Associates now owns 2,361,396 shares of the healthcare conglomerate’s stock worth $1,380,661,000 after buying an additional 587,088 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UNH traded down $1.05 during midday trading on Monday, reaching $511.95. The stock had a trading volume of 4,182,056 shares, compared to its average volume of 3,404,681. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a market cap of $471.14 billion, a PE ratio of 33.35, a P/E/G ratio of 1.53 and a beta of 0.62. The firm has a 50 day simple moving average of $559.83 and a 200-day simple moving average of $561.31.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. The business had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm’s revenue for the quarter was up 9.2% on a year-over-year basis. During the same quarter in the prior year, the business earned $6.56 EPS. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were given a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.64%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s payout ratio is 54.72%.

Analyst Upgrades and Downgrades

UNH has been the topic of a number of analyst reports. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Monday, December 9th. Hsbc Global Res lowered UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Thursday, October 17th. Truist Financial decreased their target price on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research note on Monday. Cantor Fitzgerald increased their target price on shares of UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a research note on Wednesday, October 16th. Finally, Barclays raised their price objective on UnitedHealth Group from $603.00 to $655.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 27th. Three equities research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $627.58.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.